Fabio Farinati
#162,545
Most Influential Person Now
Researcher
Fabio Farinati's AcademicInfluence.com Rankings
Fabio Farinaticomputer-science Degrees
Computer Science
#9467
World Rank
#9941
Historical Rank
Algorithms
#385
World Rank
#390
Historical Rank
Computational Linguistics
#2289
World Rank
#2312
Historical Rank
Machine Learning
#4146
World Rank
#4195
Historical Rank
Download Badge
Computer Science
Fabio Farinati's Degrees
- PhD Computer Science University of Milan
- Masters Artificial Intelligence University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Fabio Farinati Influential?
(Suggest an Edit or Addition)Fabio Farinati's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients (1998) (1263)
- Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness (2008) (422)
- Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) (2000) (414)
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. (2004) (409)
- Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. (1995) (390)
- Prospective validation of the Barcelona Clinic Liver Cancer staging system. (2006) (375)
- Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) (2002) (324)
- Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma (2004) (305)
- Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis (1999) (282)
- Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. (2010) (262)
- Oxidative DNA damage accumulation in gastric carcinogenesis (1998) (258)
- Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. (1994) (245)
- Association between reactive oxygen species and disease activity in chronic hepatitis C. (1996) (243)
- Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither? (2006) (241)
- Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? (2006) (201)
- Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis (2020) (191)
- How should patients with hepatocellular carcinoma be staged? (2000) (173)
- Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. (2013) (172)
- Prognosis of untreated hepatocellular carcinoma (2015) (170)
- Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. (2015) (166)
- The long term outcome of gastric non-invasive neoplasia (2003) (166)
- Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience (2010) (152)
- Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. (2011) (145)
- Autoimmune gastritis: Pathologist's viewpoint. (2015) (138)
- Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. (2015) (131)
- Surveillance for Hepatocellular Carcinoma in Elderly Italian Patients With Cirrhosis: Effects on Cancer Staging and Patient Survival (2004) (130)
- Alpha‐fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis (2012) (129)
- Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. (1999) (127)
- Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost‐benefit analysis while awaiting data on sorafenib safety (2010) (113)
- Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis? (2007) (113)
- Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma (2016) (113)
- Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. (2011) (111)
- Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. (2014) (108)
- The role of cysteine and serine proteases in colorectal carcinoma (1999) (107)
- Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. (2014) (107)
- Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria (2007) (106)
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. (1990) (104)
- DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. (2001) (102)
- Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. (1993) (101)
- Autoimmune gastritis: histology phenotype and OLGA staging (2012) (100)
- Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. (1996) (96)
- Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation (1996) (96)
- Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer (2008) (95)
- Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. (1991) (94)
- The changing scenario of hepatocellular carcinoma over the last two decades in Italy. (2012) (92)
- Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: Comparative analysis from two centers (2009) (91)
- Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy (2020) (87)
- Effect of the Etiology of Viral Cirrhosis on the Survival of Patients with Hepatocellular Carcinoma (2006) (86)
- Gastric epithelial dysplasia. How clinicopathologic background relates to management (1995) (84)
- Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study (2009) (84)
- Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice (2018) (82)
- Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon (2017) (81)
- Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway (2008) (81)
- Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma (2007) (79)
- Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. (2017) (77)
- Hepatic and extrahepatic malignancies in primary biliary cirrhosis (1999) (76)
- OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long‐term Follow‐up Study of 7436 Patients (2018) (76)
- Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer (2007) (76)
- Squamous cell carcinoma antigen in human liver carcinogenesis (2007) (75)
- The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. (1986) (74)
- The evolutionary scenario of hepatocellular carcinoma in Italy: an update (2017) (71)
- Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism (2008) (70)
- Helicobacter pylori CagA Status, Mucosal Oxidative Damage and Gastritis Phenotype: A Potential Pathway to Cancer? (2003) (70)
- Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis. (2017) (68)
- A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma (2017) (68)
- Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. (2006) (67)
- Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non‐ulcerous patients: is the bacterium a promoter of intestinal metaplasia? (1993) (67)
- Hepatocellular carcinoma in primary biliary cirrhosis. (1994) (67)
- Fas / FasL system, IL‐1β expression and apoptosis in chronic HBV and HCV liver disease (2008) (66)
- Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissue. (1985) (65)
- Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. (2012) (62)
- A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis (2014) (60)
- Cysteine and serine proteases in gastric cancer (1995) (59)
- Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? (2006) (57)
- Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway. (2014) (57)
- Antibody to hepatitis C virus in hepatocellular carcinoma (1990) (56)
- Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). (2006) (56)
- Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance (2007) (55)
- Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use (2014) (55)
- The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. (2013) (55)
- Circulating free DNA in the progression of liver damage to hepatocellular carcinoma (2013) (54)
- Proteases in gastrointestinal neoplastic diseases. (2000) (54)
- Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? (2009) (53)
- Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma (2012) (53)
- Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. (2017) (52)
- Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2016) (52)
- When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. (2018) (52)
- The changing scenario of hepatocellular carcinoma in Italy: an update (2014) (51)
- Barrett's Esophagus and Adenocarcinoma Risk: The Experience of the North-Eastern Italian Registry (EBRA) (2012) (51)
- Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals (2017) (51)
- Oxidative Stress and Inducible Nitric Oxide Synthase Induction in Carcinogenesis (2010) (51)
- Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. (2013) (51)
- Hepatocellular carcinoma in patients with cryptogenic cirrhosis. (2009) (51)
- Advanced precancerous lesions in the liver. (2013) (51)
- Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients (2013) (50)
- Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial. (2002) (50)
- Comparison between alcohol‐ and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome (2016) (50)
- Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. (2009) (49)
- Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. (2003) (47)
- Gastrointestinal stromal tumors: report of an audit and review of the literature (2009) (46)
- HBV and HCV infections in heart transplant recipients. (2001) (46)
- Long-Term Follow-up of Barrett’s Epithelium: Medical Versus Antireflux Surgical Therapy (2011) (46)
- Diagnostic and prognostic role of SCCA‐IgM serum levels in hepatocellular carcinoma (HCC) (2014) (46)
- Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. (2002) (45)
- Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. (1996) (45)
- Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. (2004) (44)
- Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma (2017) (44)
- Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. (1996) (43)
- The “three‐in‐one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice (2018) (42)
- Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. (2002) (42)
- The survival benefit of liver transplantation in hepatocellular carcinoma patients. (2010) (42)
- Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor? (1995) (41)
- Extended lymphadenectomy (D2) in patients with early gastric cancer. (2005) (41)
- Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial. (2013) (41)
- Hepatocellular carcinoma in patients without cirrhosis in Italy. (2013) (41)
- Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis (1994) (39)
- Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma (2011) (39)
- Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age: a morphometric study. (1993) (39)
- Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). (2001) (38)
- Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function (2011) (38)
- Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype. (2014) (38)
- Significance of Platelet and AFP Levels and Liver Function Parameters for HCC Size and Survival (2014) (38)
- BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20‐year survey by the Italian Liver Cancer group (2015) (38)
- Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. (2011) (38)
- Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). (2010) (37)
- Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features. (1992) (37)
- Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease (2001) (36)
- Barrett’s epithelium after antireflux surgery (2005) (36)
- The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study (2017) (36)
- Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. (2005) (35)
- White paper of Italian Gastroenterology: delivery of services for digestive diseases in Italy: weaknesses and strengths. (2014) (35)
- Digestive and Liver Disease (2011) (35)
- Partial hepatectomy as first‐line treatment for patients with hepatocellular carcinoma (2007) (34)
- Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. (2019) (34)
- Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role (1997) (34)
- Atrophic gastritis: pathology and endoscopy in the reversibility assessment (2003) (34)
- Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases (2019) (34)
- Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. (2006) (33)
- Complications of radiofrequency thermal ablation in hepatocellular carcinoma: what about “explosive” spread? (2006) (33)
- Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study. (2014) (33)
- Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinoma (2010) (33)
- Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. (2011) (32)
- Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. (1997) (31)
- A Liver Index and its Relationship to Indices of HCC Aggressiveness (2016) (31)
- Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology. (1995) (31)
- Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. (2013) (31)
- Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group (2018) (30)
- Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers (2008) (30)
- Correction: Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma (2012) (30)
- The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results. (2007) (29)
- Estrogens receptors and oxidative damage in the liver (2002) (29)
- Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype (2007) (29)
- Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database (2021) (28)
- Effect of age on gastric acid, pepsin, pepsinogen group A and gastrin secretion in peptic ulcer patients. (1994) (28)
- Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer. (1997) (27)
- Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis. (2016) (27)
- Chemoprevention of colorectal cancer: feasibility in everyday practice? (2008) (27)
- Effects of chronic ethanol consumption on carcinogen activating and detoxifying systems in rat upper alimentary tract tissue. (1989) (27)
- Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? (2004) (27)
- Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer? (1991) (26)
- Helicobacter pylori and the liver: any relationship? (1998) (26)
- Gastrointestinal stromal tumors: the histology report. (2011) (25)
- Years of life that could be saved from prevention of hepatocellular carcinoma (2016) (25)
- Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis (2015) (25)
- Non-invasive neoplasia of the stomach (2003) (25)
- Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study (2013) (25)
- Early and advanced gastric cancer during follow‐up of apparently benign gastric ulcer: Significance of the presence of epithelial dysplasia (1987) (24)
- Low Alpha-Fetoprotein HCC and the Role of GGTP (2014) (24)
- Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. (2012) (24)
- Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer. (1993) (24)
- H. pylori eradication and gastric precancerous lesions. (1998) (24)
- Risk of COVID-19 in celiac disease patients (2020) (23)
- CA 19-9 determination in gastric justice: Role in identifying gastric cancer and high risk patients (1988) (23)
- Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study (2018) (23)
- Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients (2018) (23)
- Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. (2012) (23)
- Gastrin: from pathophysiology to cancer prevention and treatment (2014) (23)
- Early miR-223 Upregulation in Gastroesophageal Carcinogenesis (2017) (22)
- Polyclonal and monoclonal B lymphocytes response in HCV‐infected patients treated with direct‐acting antiviral agents (2017) (22)
- PD‐L1 overexpression in ampulla of Vater carcinoma and its pre‐invasive lesions (2017) (22)
- Follow-up in gastric dysplasia patients. (1989) (21)
- Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy (2005) (21)
- Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. (2016) (21)
- Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature. (2006) (21)
- The phenotype of gastric mucosa coexisting with Barrett's oesophagus (2001) (21)
- Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation (2013) (21)
- Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens (2021) (21)
- PD-L1 expression in gastroesophageal dysplastic lesions (2019) (20)
- Is mild gastric epithelial dysplasia an indication for follow-up? (1983) (20)
- Sex hormone profile and endometrial cancer risk in primary biliary cirrhosis: a case-control study. (2002) (20)
- TACE treatment in hepatocellular carcinoma: what should we do now? (2012) (20)
- Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high‐risk patients and gastric cancer (1983) (20)
- Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer (1993) (19)
- Clinical markers of slow healing and relapsing gastric ulcer. (1987) (19)
- Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. (1991) (19)
- Unresectable hepatocellular carcinoma in cirrhosis (1996) (19)
- Hepatic spleen nodules (HSN) (2010) (18)
- Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma (1992) (18)
- Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. (2022) (18)
- CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels. (1994) (18)
- Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia. (2004) (18)
- Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis? (2001) (17)
- Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria (2019) (17)
- Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy (2012) (17)
- Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research (2018) (17)
- An HCC Aggressiveness Index and Blood GTP, Bilirubin and Platelet Levels (2016) (17)
- Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma (2006) (17)
- Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases (2010) (17)
- Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance (2020) (16)
- From Barrett metaplasia to esophageal adenocarcinoma: the molecular background. (2016) (16)
- Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort study (2017) (16)
- Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis (2021) (16)
- Medical and gastroenterological education during the COVID-19 outbreak (2020) (16)
- Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters. (2014) (15)
- Capecitabine in advanced hepatocellular carcinoma: A multicenter experience. (2019) (15)
- Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications (2021) (15)
- Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand? (2022) (15)
- Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas (2021) (15)
- Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective? (2001) (15)
- Tamoxifen treatment in hepatocellular carcinoma. (1996) (15)
- Determinants for the development of chronic atrophic gastritis and intestinal metaplasia in the stomach. (1995) (14)
- Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. (2015) (14)
- Rise and fall of HCV‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA.LI.CA centres (2013) (14)
- MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions. (2018) (14)
- Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum. (2004) (14)
- More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC (2021) (13)
- Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers. (2019) (13)
- Occult hepatitis B virus infection. (2000) (13)
- Micronuclei and broken eggs in human liver carcinogenesis. (2008) (13)
- Sorafenib use in the transplant setting (2014) (13)
- Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosis (2013) (13)
- Lymphadenectomy in patients with gastric cancer. A critical review. (2003) (13)
- Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now? (2021) (13)
- Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor (2015) (12)
- Megestrol treatment in patients with hepatocellular carcinoma (2001) (12)
- Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience (2015) (12)
- Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination (2011) (12)
- Changes in microRNA expression during disease progression in patients with chronic viral hepatitis (2015) (12)
- Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients (2022) (12)
- Videolaparoscopic microwave ablation in patients with HCC at a European high‐volume center: Results of 815 procedures (2019) (12)
- Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis. (2020) (12)
- Cysteine and serine proteases in colorectal cancer (1998) (12)
- SARS-CoV-2 and hepatitis. (2020) (11)
- Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation (2021) (11)
- miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis12 (2018) (11)
- Upper gastrointestinal injury caused by diquat. (1992) (11)
- An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells (2005) (11)
- Epithelial Dysplasia in Endoscopic Gastric Mucosal Biopsies (1981) (11)
- CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? (1991) (11)
- Alpha‐fetoprotein in hepatocellular carcinoma surveillance: Wake not the dead (2011) (10)
- Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention (2011) (10)
- 109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B) (2013) (10)
- MODERATELY OR WELL-DIFFERENTIATED HEPATOCELLULAR-CARCINOMA AND LIVER TRANSPLANTATION (2004) (10)
- Immunotherapy for gastric premalignant lesions and cancer. (2012) (10)
- The role of anti‐oxidants in the chemoprevention of gastric cancer (1994) (10)
- Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions (2003) (10)
- BRAF p.V600E‐specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling (2017) (9)
- Helicobacter pylori and gastric cancer: both primary and secondary preventive measures are required. (1999) (9)
- [Role and behavior of cathepsin B and cathepsin L in gastric cancer]. (1995) (9)
- The mechanisms underlying hepatitis C virus genotype 3-mediated liver damage. (2003) (9)
- Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation (2020) (9)
- Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma (2005) (9)
- Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: Scratch and win (2005) (9)
- Gastric epithelial dysplasia in relapsing and nonrelapsing gastric ulcer. (1982) (9)
- Monofocal hepatocellular carcinoma: How much does size matter? (2020) (9)
- Hepatocellular carcinoma, alcohol, and cirrhosis: Facts and hypotheses (1991) (9)
- Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. (1995) (9)
- Sex hormones and trace elements in rat CCL4-induced cirrhosis and hepatocellular carcinoma. (1993) (9)
- Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications (2022) (9)
- Gastric epithelial dysplasia. (1991) (9)
- Fatal HBV-Related Liver Failure during Lamivudine Therapy in a Patient with Non-Hodgkin's Lymphoma (2008) (9)
- Diagnosis of gastric carcinoma in Japan and western countries (1997) (8)
- Experimental hepatology applied to stem cells. (2008) (8)
- CA 19-9 determination in gastric juice: role in identifying gastric cancer and high risk patients. (1988) (8)
- Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study. (2020) (8)
- Metabolic disorders across hepatocellular carcinoma in Italy (2018) (8)
- Mutagenic activity in gastric juice and urine of subjects with chronic atrophic gastritis, gastric epithelial dysplasia and gastric cancer. (1989) (8)
- Ten-Year Outcome of Radiofrequency Thermal Ablation for Hepatocellular Carcinoma: An Italian Experience (2012) (8)
- Zinc, iron, and peroxidation in liver tissue (2007) (8)
- Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis (2018) (7)
- Perendoscopic gastric pH determination. Simple method for increasing accuracy in diagnosing chronic atrophic gastritis. (1987) (7)
- [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer]. (1999) (7)
- Pattern of macrovascular invasion in hepatocellular carcinoma (2021) (7)
- Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients (2021) (7)
- Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma. (1996) (7)
- Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre‐sorafenib era (2010) (6)
- Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2021) (6)
- Association of abnormal plasma bilirubin with aggressive HCC phenotype (2014) (6)
- Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study (2017) (6)
- The Risk of Malignancies in Celiac Disease—A Literature Review (2021) (6)
- Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter (2021) (6)
- Capecitabine in advanced hepatocellular carcinoma. (2016) (6)
- Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions (2021) (6)
- Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation? (1993) (6)
- Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital (2020) (6)
- Occurrence of an atypical alkaline phosphatase fraction ("biliary") in primary liver cancer. (1983) (6)
- Gastroenterological oncology: a top priority. (2000) (6)
- HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game". (2017) (6)
- A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer (2021) (6)
- HELICOBACTER PYLORI AND ATROPHIC GASTRITIS : IMPORTANCE OF THE CAGA STATUS. AUTHORS' REPLY (1996) (6)
- Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease. (1995) (6)
- Apoptosis in alcoholic hepatitis. (2002) (5)
- MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer (2012) (5)
- Gastric ulcer and stomach aging: pathophysiology and clinical implications. (1988) (5)
- Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors. (2022) (5)
- The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer. (1995) (5)
- Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative Therapies (2011) (5)
- Consensus statement on diet and gastric cancer. Gastric Cancer Panel. (1997) (5)
- Transarterial chemoembolization in Child–Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea (2010) (5)
- Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20‐year period: a multicentre Italian study (2011) (5)
- Cholestatic jaundice as the presenting symptom of small cell lung cancer. (1990) (5)
- Octreotide and hepatocellular carcinoma (2007) (4)
- Treatment allocation in patients with hepatocellular carcinoma: Need for a paradigm shift? (2021) (4)
- Consensus statement on cereals, fibre and colorectal and breast cancers. Proceedings of the European Cancer Prevention consensus meeting. Santa Margheritia, Italy, 2-5 October 1997. (1998) (4)
- Gastric juice CEA levels: importance of age and gastric mucosal damage. (1986) (4)
- Risk of hepatocellular carcinoma in alcoholic cirrhosis. (2008) (4)
- Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma (2021) (4)
- There is much more to rely on histology than the sole endoscopy tells us (2019) (4)
- Re: Helicobacter pylori and atrophic gastritis: importance of the cagA status. (1996) (4)
- Cysteine and glutathione in the liver of patients with primary biliary cirrhosis. (1996) (4)
- Molecular Targeted Therapy in Hepatocellular Carcinoma: Present Achievements and Future Challenges (2012) (4)
- Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal ulcer disease. (1992) (4)
- Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer. (1986) (4)
- Ethanol and carcinogenesis: promoter, co-carcinogen or innocent bystander ? (1988) (4)
- The coeliac stomach: A review of the literature. (2020) (4)
- Non-invasive neoplasia of the stomach. (2005) (4)
- Histological modifications of gastric mucosa and functional correlations in rheumatoid arthritis (1989) (4)
- Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization (2021) (4)
- Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment (2022) (4)
- Recent Trends in Adjuvant Therapy for Gastric Cancer (1992) (3)
- Up and down regulation of apoptosis in hepatitis C virus-related liver damage. (2004) (3)
- Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis (1992) (3)
- Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases (2019) (3)
- Predictive factors of HCC recurrence after liver transplantation (OLT): An interim analysis (2003) (3)
- Real-time determination of gastric juice pH with EndoFaster® for atrophic gastritis assessment. (2022) (3)
- HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. (2008) (3)
- Estrogen receptors and oxidative damage in the liver (2002) (3)
- Aspartic proteinases and gastrin in the diagnosis of gastric cancer and gastric precancerous changes (1993) (3)
- HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue? (2018) (3)
- [Prognostic role of cisteine and serin proteases in gastriC cancer]. (1996) (3)
- Direct involvement of human gastric mucosa in the activation of alimentary pro-carcinogens. (1991) (3)
- A tricky case of pancreatic arteriovenous malformation: the role of endoscopic ultrasound in the diagnosis of this rare condition (2018) (3)
- Systemic therapies for hepatocellular carcinoma: an evolving landscape (2021) (3)
- Adequate Interval For Hepatocellular Carcinoma Surveillance (2013) (3)
- Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland (1992) (3)
- Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma (2021) (3)
- Transcatheter arterial chemoembolization in hepatocellular carcinoma (1998) (3)
- TAG-72 serum determination in early and advanced gastric cancer. (1989) (3)
- Granular cell myoblastoma of the esophagus: endoscopic diagnosis and therapy. (1985) (3)
- The war of the worlds: metaplastic versus nonmetaplastic atrophic gastritis. (2011) (3)
- Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (2022) (3)
- Monitoring liver regeneration after right hepatectomy. (1985) (3)
- [274] SURVEILLANCE FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IS IT EFFECTIVE IN INTERMEDIATE/ADVANCED CIRRHOSIS? (2007) (3)
- SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences. (2020) (3)
- EFFECTS OF N-ACETYL-L-CYSTEINE IN PATIENTS WITH CHRONIC ATROPHIC GASTRITIS AND NONULCER DYSPEPSIA: A PHASE III PILOT STUDY (1997) (3)
- Consensus statement on cereals, fibre and colorectal and breast cancers ECP consensus panel on cereals and cancer (1998) (3)
- Neuroendocrine pancreatic tumor associated with a cerebral neurofibroma. A case Report. (2014) (2)
- Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease. (2023) (2)
- [Benign and malignant gastric ulcers: is their localization relevant in their differential diagnosis?]. (1983) (2)
- Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis. (1996) (2)
- Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy (2019) (2)
- A new method for detecting anti Helicobacter pylori antibodies: An analytical and clinical evaluation (1994) (2)
- Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer (1990) (2)
- A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy (2005) (2)
- Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs (2021) (2)
- Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. (1997) (2)
- Alpha-synuclein pathology and enteric glia in advanced Parkinson's disease: A study from gastrointestinal biopsies (2021) (2)
- Epstein-Barr virus associated gastric dysplasia: a new rare entity? (2021) (2)
- Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! (2021) (2)
- Expression of squamous cell carcinoma antigen in hepatocellular carcinoma and its precursors (2006) (2)
- Circulating Microparticles and Risk of Portal Vein Thrombosis in Patients with Liver Cirrhosis and Hepatocellular Carcinoma (2016) (2)
- Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. (2021) (2)
- Changes in the gastric mucosa after ranitidine treatment in duodenal ulcer (1982) (2)
- Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study (2015) (2)
- Normal and Pathological Human Liver Dimethylnitrosamine Demethylase Activity and Capacity for 2-Aminofluorene and Nitrosopyrrolidine Activation in vitro (1989) (2)
- Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter (2022) (2)
- Precancerous lesions of the digestive tract: The 18th Annual Symposium of the European Cancer Prevention Organisation Maastricht, The Netherlands, 12-14 October 2000 (2000) (2)
- Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms (2021) (2)
- Coffee, chronic diseases and cancer (2013) (2)
- Transarterial chemoembolization for hepatocellular carcinoma in clinical practice: temporal trends and survival outcomes over the last three decades in Italy (2022) (1)
- Early and very early HCC (2007) (1)
- Comparative study of c-myc mRNA in chronic active hepatitis, cirrhosis, and HCC (2001) (1)
- No need of transforming gastroenterology units to covid units at the time of SARS-COV2 infection - a single-center analysis from northern italy (2020) (1)
- Histological changes induced by pirenzepine in the gastric mucosa of patients with duodenal ulcer: preliminary remarks (1985) (1)
- OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B) (2013) (1)
- Efficacy of teduglutide in a patient with Crohn’s disease and short bowel syndrome on enteral nutrition: let’s start to think out of the box (2019) (1)
- Tumour markers in gastrointestinal malignancies: an update (1992) (1)
- Mismatch repair status and gastro‐oesophageal dysplasia: need for a dedicated gastrointestinal pathologist? (2022) (1)
- Hepatocellular carcinoma (HCC) and hepatitis viruses: Oxidative damage correlate with cell immortalization and miRNA expression (2009) (1)
- Zinc and Digestive Diseases (1996) (1)
- [Peptic ulcer and liver cirrhosis. Clinico-epidemiologic considerations]. (1990) (1)
- AF.79 EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH METABOLIC-DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ITALY (2021) (1)
- Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor (GIST) patients. An Interdisciplinary GIST Group Study (432) (2010) (1)
- [Bleeding of gastric ulcers. Epidemiologic, clinical and functional characteristics]. (1990) (1)
- Alpha Fetoprotein in Hepatocellular Carcinoma: Reply to Letter to Editor (2006) (1)
- The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer. (2014) (1)
- Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection (2022) (1)
- P.03.14 UTILITY OF PANCREATIC CYSTIC FLUID GLUCOSE IN ADDICTION TO CEA IN THE DIFFERENTIATION BETWEEN NON-MUCINOUS FROM PRE-MALIGNANT MUCINOUS PANCREATIC CYSTS (2019) (1)
- The effect of full-dose famotidine therapy on mucus and pepsin concentrations (1990) (1)
- 249 Expression of squamous cell carcinoma antigen in hepatocellular carcinoma and its precursors (2004) (1)
- 61 INCIDENCE AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PRIMARY BILIARY CIRRHOSIS. COMPARATIVE ANALYSIS FROM TWO EUROPEAN REFERRAL CENTERS (2009) (1)
- The role of hepatitis C virus eradication with DAA on insulin resistence regulation (2018) (1)
- Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer (2001) (1)
- The risk of gastric dysplasia in medical long-term treatment of peptic ulcer disease. (1985) (1)
- Predictors of duodenal ulcer relapse: a 12-month study in untreated patients. (1985) (1)
- Coffee consumption and pancreatic cancer: a cancer -controlled case-control study. (1994) (1)
- Digestive oncology: It's now or never. (2012) (1)
- Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma: Beyond Rigid Staging Systems Towards a More Personalized Therapeutic Approach (2021) (1)
- A reappraisal of the Barcelona Clinic Liver Cancer model: natural history of untreated ‘intermediate stage’ hepatocellular carcinoma (2004) (1)
- F-45 Neoangiogenesis after TACE: any difference between conventional and DC-Beads-mediated transarterial chemoembolization? (2013) (1)
- Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery. (2022) (1)
- Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization (2017) (1)
- D2 or non D2-lymphadenectomy in gastric cancer (2004) (1)
- Apoptosis and cytoproliferation in chronic HCV-related hepatitis (1998) (1)
- Letter: gastric atrophy as a precursor of gastric cancer – authors’ reply (2012) (1)
- Oxidative DNA damage in ulcerative colitis (2000) (1)
- Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis. (2021) (1)
- The Role of Cysteine and Serine Proteases in Gastric Carcinogenesis and Their Prognostic Impact in Gastric Cancer (1997) (1)
- Non-invasive evaluation of change in liver fibrosis after viral eradication in patients with HCV related cirrhosis (2018) (1)
- OC-26 The emerging impact of HCC-NAFLD in Italy (2012) (1)
- Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. (2022) (1)
- Interleukin 1β and tumor necrosis factor-α polymorphisms in autoimmune gastritis. (2011) (1)
- Daily interferon monotherapy versus daily interferon plus amantadinein the treatment of naive chronic hepatitis C patients: Short-termresponse (2000) (1)
- Helicobacter pylori CagA+ve infection increases the oxidative DNA damage of gastric mucosa (2000) (1)
- 788 INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE? (2009) (1)
- Semiannual versus annual surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma: Is there a winner? (2009) (1)
- Gastrin and gastric cancer (1993) (1)
- THRICE-YEARLY RHYTHM OF DUODENAL ULCER DISEASE (1993) (1)
- Epidemiological trends of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease in Italy (2020) (1)
- Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues. (2020) (1)
- Survival in untreated and treated patients with HCC on cirrhosis according to the stage and treatment procedure: analysis of 1187 cases. (2004) (0)
- Correction to: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (The American Journal of Gastroenterology, (2016), 111, 1, (70-77), 10.1038/ajg.2015.389) (2018) (0)
- P0329 : The ITA.LI.CA staging system for patients with hepatocellular carcinoma: A multicenter cohort study (2015) (0)
- Effects of nizatidine on gastric acid and bicarbonate secretion (1993) (0)
- Gastric enterochromaffin-like cells (ECL) hyperplasia: Clinical findings and correlation with plasma ghrelin levels (2006) (0)
- P39: Therapeutic drug monitoring of ribavirin predicts SVR and development of anemia in boceprevir‐based triple regimens (2014) (0)
- Hormonal treatment of hepatocellular carcinoma. (1991) (0)
- Chronic atrophic gastritis (CAG) and Helicobacter pylori infection eradication: A 3 years follow-up (2001) (0)
- OC.07.6 SERUM BIOMARKERS CAN IDENTIFY PATIENTS WITH AUTOIMMUNE AND H. PYLORI-RELATED ATROPHIC GASTRITIS AND DIFFERENTIATE THOSE WITH ADVANCED GASTRIC CHANGES (2016) (0)
- OC.15.6: Autoimmune Gastritis with Previous or Concurrent H. Pylori Infection Presents Distinct Functional and Morphological Features (2017) (0)
- S1574 Correlation Between Oncoprotein 18/Stathmin and Apoptotic Mediators in Chronic HCV-Related Liver Disease (2009) (0)
- Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma (2023) (0)
- Sa1717 mTOR and LC3 Gene and Protein Expression in Chronic Liver Disease and in Primary and Secondary Human Liver Cancer (2015) (0)
- OC.08.4 ANTIBIOTIC RESISTANCE TRENDS OF ITALIAN H. PYLORI NAÏVE PATIENTS BETWEEN 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Extrinsic and intrinsic apoptosis pathways in chronic liver diseases (2008) (0)
- OC.06.3 DUODENUM FINDINGS IN GASTRIC DISEASES: A RETROSPECTIVE HISTOLOGICAL EVALUATION (2019) (0)
- Clinical effectiveness of enhanced surveillance in “super-high risk” cirrhotics as evaluated in the ITA.LI.CA database (2017) (0)
- Management of hepatocellular carcinoma in elderly patients: an Italian %26quot;in field%26quot; experience (2014) (0)
- OC.07.6 CAPECITABINE IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER EXPERIENCE (2019) (0)
- M1986 The Tumor Marker Behavior of Proteolytic Enzymes in Colorectal Cancer (2008) (0)
- Decreased hypercoagulable state in hepatitis C virus-cirrhotic patients treated with DAA: the outcome revolution (2017) (0)
- H-pylori infection as the major determinant for oxidative DNA adducts formation in gastric mucosa. (1996) (0)
- [Development of gastric carcinoma at the site of a preceding peptic ulcer after 10 years]. (1990) (0)
- P.09.9: Vascular Endothelial Growth Factor and Hypoxia Inducible Factor: Prognostic Role in HCC Patients Undergoing Conventional and Deb-Mediated Chemoembolization (2017) (0)
- T-4 A 20-years survey by ITA.LI.CA on hepatocellular carcinoma (HCC) in HCV-related cirrhosis (2011) (0)
- Helicobacter pylori Infection - The Link Between Oxidative Damage, Cell Proliferation, Apoptosis, and Gastric Cancer 82 (2014) (0)
- The concept of time-varying therapeutic hierarchy for patients with hepatocellular carcinoma: a multicenter cohort study. On behalf of the ITA.LI.CA study group (2020) (0)
- OC.03.1 ANALYSIS OF MICRORNA EXPRESSION PROFILES IN CHRONIC HEPATITIS AND DEVELOPMENT OF BIOINFORMATIC METHODS FOR PREDICTION OF MICRORNA TARGETS (2010) (0)
- P38: Autophagy evaluation in chronic liver disease progression (2014) (0)
- Osteopontin-Igm as a Marker for the Diagnosis of Hepatocellular Carcinoma (2009) (0)
- Abnormal microvasculature in chronic viral hepatitis (2017) (0)
- P1301 THE ITA.LI.CA CRITERIA TO SELECT PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION: A NOVEL APPROACH BASED ON TRANSPLANT BENEFIT ANALYSIS (2014) (0)
- P989 A NOVEL SIMPLIFIED CHILD–TURCOTTE–PUGH SCORE FOR PROGNOSTIC ASSESSMENT AND THERAPEUTIC DECISION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2014) (0)
- Helicobacter pylori (HP) eradication does not influence the natural history of gastric precancerous changes (1997) (0)
- [The use of intra-arterial lipiodol in assessing hepatocarcinomas treated by percutaneous alcoholization. The initial experience]. (1992) (0)
- T-45 Improved diagnostic accuracy for HCC using a combination of IgM-linked biomarkers (2011) (0)
- Clinical effectiveness of enhanced surveillance in “super-high risk” cirrhotics as evaluated in the ITA.LI.CA. Study Group (2018) (0)
- Sa1793 The Unfolded Protein Response and Autophagy in Chronic Liver Diseases, HCC and Metastases (2016) (0)
- Reply (2019) (0)
- Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: A new potential therapeutic target? (2021) (0)
- Monofocal HCC: Milan Criteria or BCLC staging system? An analysis of the ITA.LI.CA. Database (2018) (0)
- Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. (2009) (0)
- Letter to the editor (0)
- Daily interferon monotherapy versus daily interferon plus amantadine in the treatment of naive chronic hepatitis C: End of treatment response (2000) (0)
- OC.03.1 LOW ADHERENCE TO WORLD CANCER RESEARCH FUND (WCRF) LIFESTYLE RECOMMENDATIONS AFFECTS THE METABOLISM AND ESOPHAGEAL MICROBIOTA COMPOSITION IN PATIENTS WITH BARRETT'S ESOPHAGUS (2020) (0)
- Anorexia and resting energy-expenditure (REE) in cirrhotic patients:Role of plasma concentrations of leptin and tumor necrosisfactor-α (TNF-α) (2000) (0)
- OC.05.2 INCREASING EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN ITALY (2020) (0)
- Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC) (2014) (0)
- Apoptosis and cytoproliferation in HCV-related liver damage (1998) (0)
- OXIDATIVE DAMAGE, CELL IMMORTALIZATION AND miRNA EXPRESSION IN HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS (2009) (0)
- Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (2022) (0)
- Extension of the concept of salvage liver transplantation for patients with hepatocelluar carcinoma (2009) (0)
- Chronic atrophic gastritis: Helicobacter infection, gastric mucosa glutathione (GSH) and gastric juice vitamin C (1993) (0)
- The Fate of Barrett's Epithelium Under Acid Suppression Obtained by Medical or Surgical Therapy (2011) (0)
- HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC) (2018) (0)
- P.05.21 ROLE OF THE ROME III QUESTIONNAIRE FOR IBS IN THE WORK UP OF PATIENTS REFERRED FOR SELFREPORTED MILK INTOLERANCE (2013) (0)
- 637 FAS/FASL system and IL-1β in the natural history of chronic liver disease from hepatitis to cancer (2003) (0)
- 513 HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS VIRUSES: OXIDATIVE DAMAGE CORRELATE WITH CELL IMMORTALIZATION AND MIRNA EXPRESSION (2009) (0)
- Squamous cell carcinoma antigen in human liver carcinogenesis. (IF 2.426) (2008) (0)
- Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test (2016) (0)
- The time-varying survival benefit of HCC treatment: a multicenter cohort study (2019) (0)
- Laparoscopic liver resection versus transarterial chemoembolization for hepatocellular carcinoma in child B cirrhosis: a propensity score analysis (2019) (0)
- PC.01.6 MANAGEMENT OF HCC IN ELDERLY PATIENTS: AN ITALIAN “IN FIELD” EXPERIENCE (2014) (0)
- Direct comparison of 5 different treatment strategies for hepatocellular carcinoma (HCC) in cirrhosis: Survival according to disease stage. (2005) (0)
- ' s response to reviews Title : Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma (2012) (0)
- T-35 SerpinB3 downregulates the proapoptotic p66Shc protein in human hepatoma cells (2012) (0)
- 597. Combined suicide/cytokine gene therapy of hepatocellular carcinoma (2004) (0)
- Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy (2017) (0)
- OC.06.1 THE IMMUNITY-INFLAMMATION-CANCER PATHWAY IN AUTOIMMUNE GASTRITIS: ROLE OF THE OXIDATIVE STRESS (2019) (0)
- Characteristics of hepatocellular carcinoma patients with long-term survival: an ITA.LI.CA report (2019) (0)
- P.05.64 GASTRIC FUNDUS SPLENOSIS PRESENTING AS A STROMAL TUMOR AND DIAGNOSED BY ENDOSCOPIC ULTRASOUND-GUIDED SHARKCORE BIOPSY (2019) (0)
- Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria (2019) (0)
- T-56 Oxidative genomic and mitochondrial damage in relation to telomeric dysfunction in liver carinogenesis (2013) (0)
- OC.07.3 AUTOIMMUNE ATROPHIC GASTRITIS: DIFFERENCES BETWEEN HELICOBACTER PYLORI ASSOCIATED AND NON-ASSOCIATED DISEASE (2022) (0)
- P.04.11 INTRABILIARY RUPTURE OF ECHINOCOCCAL CYST: A NOT RARE COMPLICATION OF HYDATID DISEASE (2019) (0)
- T06.01.14 A SUDDEN PROPTOSIS: A CASE OF HEPATOCELLULAR CARCINOMA METASTATIC TO THE ORBIT (2020) (0)
- 740 COFFEE REDUCES OXIDATIVE DNA DAMAGE IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS BOTH AFTER ACUTE AND CHRONIC EXPOSURE (2012) (0)
- Sucralfate, ranitidine and no treatment in gastric ulcer management--a multicenter, prospective, randomized, 24-month follow-up with a study of risk factors of relapse. GISU (Interdisciplinary Group for Ulcer Study). (1992) (0)
- Monofocal hepatocellular carcinoma (HCC): Is diameter so important? Analysis on the Italian Liver Cancer (ITA.LI.CA) database between BCLC algorithm and Milan criteria (2018) (0)
- 817 SEMIANNUAL VERSUS ANNUAL SURVEILLANCE OF CIRRHOTIC PATIENTS FOR EARLY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IS THERE A WINNER? (2009) (0)
- 1071 CONVENTIONAL AND DC-Beads-MEDIATED TRANSARTERIAL CHEMOEMBOLIZATION: ANY DIFFERENCE IN NEOANGIOGENESIS? (2013) (0)
- Outcome and prognostic factors of untreated hepatocellular carcinoma (HCC) on cirrhosis: Survival analysis of 559 patients (2006) (0)
- Human gastric-mucosa can activate 2-amino-fluorene (2AF) and nitrosopyrrolidine (NPY), environmental and dietary carcinogens. (1988) (0)
- Clinical markers ofslowhealing andrelapsing gastric ulcer (2011) (0)
- P.01.34 CLEAR CELL RENAL CARCINOMA GASTRIC METASTASIS PRESENTING WITH GASTROINTESTINAL BLEEDING: A CASE REPORT (2019) (0)
- Screening for gastric malignancies: Field study in an open population at high risk (2000) (0)
- Gastric cancer (2021) (0)
- SAT-197 – Abnormal microvasculature in chronic viral hepatitis (2017) (0)
- PROGNOSTIC ROLE OF CATHEPSINS, UPA AND PAI-1 IN GASTRIC CANCER AND BEHAVIOR IN PRECANCEROUS CHANGES (1996) (0)
- O46 BARCELONA CLINIC LIVER CANCER STAGING AND THE NET BENEFIT OF LIVER RESECTION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTRE, COHORT STUDY (2014) (0)
- Real-time gastric juice analysis with EndoFaster for H. pylori diagnosis: a large, multicentre study (2022) (0)
- KI 67, Bcl-2, p53, CD 44 in hepatocellular carcinoma (HCC): Interaction between etiology, grading. Proliferation rate and prognostic role (2006) (0)
- O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2014) (0)
- PC.01.8 SERUM DETERMINATION OF SQUAMOUS CELLULAR CARCINOMA ANTIGEN AS A BIOMARKER OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER: A PHASE III STUDY (2016) (0)
- Impact of hospital volume on hepatocellular carcinoma survival in Italy (2021) (0)
- Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection (2023) (0)
- SAT-480-Long-term survivors in patients with hepatocellular carcinoma: An ITA.LI.CA report (2019) (0)
- Increased platelet aggregation in decompensated cirrhosis indicates higher risks of further decompensation and liver-related mortality (2022) (0)
- OC.04.1 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC STATUS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2014) (0)
- P.04.2 TELOMERIC DYSFUNCTION AND OXIDATIVE DNA DAMAGE IN PROGRESSION OF VIRAL HEPATITIS TO CIRRHOSIS AND HCC (2012) (0)
- OC.04.5 IMPACT OF HOSPITAL VOLUME ON HEPATOCELLULAR CARCINOMA SURVIVAL IN ITALY (2021) (0)
- Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) (2014) (0)
- CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY (2012) (0)
- T01.01.10 INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA (2020) (0)
- Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome (2021) (0)
- Helicobacter pylori infection CagA-positive increases the oxidative DNA damage of gastric mucosa (2000) (0)
- Letter: coffee and chronic liver damage (2014) (0)
- [N-acetylneuraminic acid after pentagastrin and secretin in subjects with duodenal ulcer and non-ulcerative dyspepsia]. (1986) (0)
- OLGA Gastritis Staging & Intestinal Metaplasia Histochemistry (2011) (0)
- The prognostic impat of urokinase type plasminogen activator receptor in colorectal cancer (2000) (0)
- Dimethylnitrosamine (DMN) demethylase in human and rat liver microsomes: Influence of ethanol (ETOH) (1991) (0)
- articleBax Inhibitor-1 down-regulation in the progression of chronic liver diseases (2015) (0)
- The stage of gastritis associated with barrett mucosa (2006) (0)
- Prognostic relevance of stage migration in patients with hepatocellular carcinoma: A multicenter cohort study (2016) (0)
- OXIDATIVE DAMAGE IN CHRONIC AND ACUTE LIVER DISEASE. (1996) (0)
- OC3.06.3 HYPERMETHYLATION OF TPEF AND MINT31 AS AN EARLY EVENT IN GASTRIC CARCINOGENESIS (2008) (0)
- P.1.24: SCCA-IGM AND CEA-IGM IN BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCERS (2011) (0)
- OC.07.6 THE ROLE OF HELICOBACTER PYLORI IN AUTOIMMUNE ATROPHIC GASTRITIS: DISEASE PHENOTYPE AND MIRNA EXPRESSION (2022) (0)
- Sa1338 NATURAL HISTORY OF AUTOIMMUNE GASTRITIS: PROSPECTIVE LONG-TERM FOLLOW-UP CLINICO-PATHOLOGICAL STUDY (2020) (0)
- OC.13.7: Lack of Clinical Effectiveness of Enhanced Surveillance in “Super-High Risk” Cirrhotics. an ITA.LI.CA Report (2017) (0)
- Contents, Vol. 34, 1988 (2004) (0)
- A novel simplified Child-Turcotte-Pugh score for prognostic assessment and therapeutic decision in patients with hepatocellular carcinoma (2014) (0)
- OC.14.1 IS THE ADHERENCE TO WCRF/AICR RECOMMENDATIONS INVOLVED IN BARRETT'S ESOPHAGUS ONSET AND ITS PROGRESSION TO EAC? A RETROSPECTIVE ANALYSIS IN A HIGH-RISK POPULATION (2018) (0)
- OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS (2021) (0)
- 827 THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2009) (0)
- THE ITA.LI.CA STAGING SYSTEM FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY (2015) (0)
- P53 as a prognostic predictor in hepatocellular carcinoma (HCC) (2003) (0)
- BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function (2021) (0)
- Prognostic and diagnostic role of VEGF-A and HIF-1α in hepatocellular carcinoma treated with chemoembolization (2020) (0)
- OC.05.1 IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE (2021) (0)
- OC.18.6 TNF-A AND IL-10 IN AUTOIMMUNE AND H. PYLORI-RELATED GASTRIC ATROPHY: TISSUE LEVELS IN RELATION TO THE CYTOKINES GENE POLYMORPHISM (2014) (0)
- The "very bed" H pylori: Experience on 69 consecutive patients after the failure of the second eradication treatment. (1999) (0)
- OC.06.1 BARRETT'S ESOPHAGUS: OXIDATIVE DAMAGE AND TELOMERIC DYSFUNCTION (2010) (0)
- Lowest Case Fatality Rate for Patients With Acute Pancreatitis Admitted in Gastroenterology Units in Veneto Region, Italy. (2019) (0)
- V.02.4 USEFULNESS OF ENDOSCOPIC ULTRASONOGRAPHY IN THE DIAGNOSIS OF A STRANGE ESOPHAGEAL STENOSIS (2018) (0)
- Gastric precancerous lesion follow up based on pathological evidence (2004) (0)
- OC.04.6 CIRCULATING PROSTAGLANDIN E2: A NOVEL POTENTIAL PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2021) (0)
- Gastrointestinal stromal tumours: the paradigm of a bench-to-bedside disease (2009) (0)
- The critical issue of restaging patients with hepatocellular carcinoma (2018) (0)
- Gastroesophageal junction DNA oxidative damage after H. pylori eradication in HPLC-ED and ELISA (2001) (0)
- Real-time gastric juice analysis with EndoFaster for H. pylori diagnosis: a large, multicentre study. (2022) (0)
- T-13 Protective effect of coffee on oxidative DNA damage in patients with HCV-chronic hepatitis (2011) (0)
- P.15.13 ACUTE AND CHRONIC COFFEE EXPOSURE: EFFECTS ON OXIDATIVE DNA DAMAGE AND VIRAL LOAD (2012) (0)
- Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management (2022) (0)
- 1072 TELOMERIC DYSFUNCTION IN RELATION TO OXIDATIVE DNA DAMAGE IN LIVER CARCINOGENESIS (2013) (0)
- Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance (2023) (0)
- Prognostic role of platelets-to lymphocytes ratio (PLR) and neutrophils-to-lymphocytes ratio (NLR) in hepatocellular carcinoma patients (0)
- OC.05.1 MICRORNA-21 AND MICRORNA-122: PROGNOSIS PREDICTION AND CORRELATION WITH HIF-1ALPHA IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION (2020) (0)
- TRANSARTERIAL EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA : CURRENT TRENDS (2019) (0)
- M1587 EPIYA-C Motifs Are Main Determinants of Intestinal Metaplasia and Gastric Mucosa Atrophy (2009) (0)
- OC.14.2 ENDOSCOPIC RADIOFREQUENCY ABLATION (RFA) FOR THE TREATMENT OF GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A SINGLE CENTER 5 YEARS EXPERIENCE (2020) (0)
- EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) VARIANTS IN HEPATOCELLULAR CARCINOMA AND ITS PRECURSOR (2003) (0)
- Activation by Human Gastric Mucosa of Alimentary Procarcinogens (1991) (0)
- OC.15.3: Prevalence and Pathophysiology of Gastro-Esophageal Reflux Disease in Patients with Autoimmune Gastritis (2017) (0)
- Tamoxifene treatment improves survival in patients with unresectable hepatocellular carcinoma (HCC) (1989) (0)
- [Methodological aspects of gastric acid examination]. (1986) (0)
- Primary hepatocellular carcinoma: Primary hepatocellular carcinoma. Cirrhosis, HCV and PHC (1999) (0)
- [Ultrasound guided fine-needle aspiration biopsy in the diagnosis of hepatocellular carcinoma]. (1995) (0)
- Surveillance for hepatocellular carcinoma in elderly cirrhotic patients. Effects on cancer staging and patient survival (2002) (0)
- T.08.6 CIRCULATING MICRORNA-21 AND HIF-1ALPHA IN CHRONIC LIVER DISEASES AND HEPATOCELLULAR CARCINOMA (2022) (0)
- Liver transplantation for hepatocellular carcinoma: Results of a six-year experience (1997) (0)
- High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients (2021) (0)
- F-39 Alpha-fetoprotein changes as surveillance test for hepatocellular carcinoma: results of a case-control study (2013) (0)
- Adjuvant chemotherapy and chemoimmunotherapy for gastric carcinoma (1989) (0)
- Which is the best therapy for not transplantable patients with multinodular early HCC? (2023) (0)
- Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset (2022) (0)
- T-2 The evolving clinical scenario of hepatocellular carcinoma over the last 20 years in Italy (2011) (0)
- Duodenal alpha-Synuclein pathology and enteric gliosis in advanced PD patients (2022) (0)
- Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2018) (0)
- Prognostic and diagnostic role of angiogenesis biomarkers in hepatocellular carcinoma treated with chemoembolization (2020) (0)
- [Local transcatheter arterial chemoembolization in the palliative treatment of inoperable hepatocellular carcinoma]. (1995) (0)
- α-FP increases in patients with HBeAg+ve/HBV-DNA+ve cirrhosis seroconverting to antiHBe with and without interferon (1989) (0)
- 1 OP Oxidative DNA damage in relation to estrogen receptor status in chronic liver damage and HCC (2002) (0)
- AF.24 CHARACTERISTICS OF EMPIRICAL FIRST- AND SECOND-LINE TREATMENT BETWEEN 2013-2020: ITALIAN DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Osteopontin-IgM in the diagnosis of HCC (2009) (0)
- OC.08.5 EFFECTIVENESS OF EMPIRICAL SECOND-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- T01.02.2 ENDOSCOPIC AND PATHOLOGIC SECOND OPINION FOR BARRETT'S ESOPHAGUS (BE) ASSOCIATED DYSPLASIA: THE EXPERIENCE OF A NORTHEAST REFERENCE CENTER (2020) (0)
- The tumor marker and prognostic impact of cathepsin B , cathepsin L , urokinase-type plasminogen activator and its inhibitor type-1 in colorectal cancer (2008) (0)
- Italian experience on liver transplantation for hepatocellular carcinoma (2002) (0)
- OC2.01.2 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLULAR CARCINOMA: WHEN IS IT WORTH DOING? (2008) (0)
- Effects of helicobacter pylori eradication on stomach and oesophageal morphology and biology at short time (2000) (0)
- T01.01.8 NATURAL HISTORY OF AUTOIMMUNE GASTRITIS: PROSPECTIVE LONG-TERM FOLLOW-UP CLINICO-PATHOLOGICAL STUDY (2020) (0)
- Surveillance for early diagnosis of hepatocellular carcinoma (HCC): Is it effective in intermediate/advanced cirrhosis? (2007) (0)
- Micronuclei and P53 overexpression in barrett mucosa carcinogenensis (2006) (0)
- Reply (2017) (0)
- Development of retroviral vectors for combined suicide and immunomodulating gene therapy of hepatocellular carcinoma (HCC) (2002) (0)
- P.08.22 PROGNOSTIC ROLE OF SCCA-IGM SERUM LEVELS IN HEPATOCELLULAR CARCINOMA (HCC) (2012) (0)
- LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK (2009) (0)
- Gastrin and gastric cancer. Reply (1993) (0)
- Molecular staging of HCC patients eligible for potentially radical therapies (2008) (0)
- 1003 THE EVOLVING CLINICAL SCENARIO OF HEPATOCELLULAR CARCINOMA OVER THE LAST 20 YEARS IN ITALY (2011) (0)
- [Basal and postprandial blood gastrin in peptic ulcer. The physiopathological considerations in relation to different locations of the lesion]. (1989) (0)
- Capecitabine in advanced hepatocellular carcinoma: a multicenter experience (2019) (0)
- Pro- and anti-inflammatory cytokine gene polymorphisms in autoimmune gastritis (2006) (0)
- Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series. (2022) (0)
- Barcelona Clinic Liver Cancer staging and the net benefit of liver resection for patients with hepatocellular carcinoma: a multicentre, cohort study (2014) (0)
- Systemic therapies for hepatocellular carcinoma: a recap of the current status (2018) (0)
- T-19Adherence to BCLC treatment algorithm and survival predictors in single node HCC in Italy (2016) (0)
- Grading, p53 and cd44 expression, cytoproliferation (MIB1) and tumor morphology as prognostic factors in hepatocellular carcinoma (HCC) (2001) (0)
- Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance (2023) (0)
- Determinants of gastritis in an area at high risk of gastric cancer (2000) (0)
- 360 Retroviral-mediated combined suicide and immunomodulating gene therapy of hepatocellular carcinoma (HCC): An in vitro and in vivo study (2004) (0)
- Insulin resistance improvement after effective Hepatitis C virus eradication and its role on the onset of complications of advanced liver disease (2018) (0)
- Liver transplantation for hepatocellular carinoma (HCC): Predictive factors of HCC recurrence, an interim analysis (2003) (0)
- Sa1339 INTEROBSERVER CONSISTENCY ON THE HISTOLOGICAL ASSESSMENT OF SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA (2020) (0)
- Prevlence and outcome of De novo malignancies after liver transplantation (OLT) (1998) (0)
- Hepatocellular carcinoma (HCC): Tissue demonstration of HCV-related antigens (1991) (0)
- SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences (2020) (0)
- Epidemiology and early diagnosis of hepatocellular carcinoma (1997) (0)
- Angiogenesis during trans-cathether arterial chemoembolisation (TACE) in hepatocellular carcinoma (HCC) (2007) (0)
- Poster Presentations (2014) (0)
- PA.31 TYPE I GASTRIC CARCINOIDS: A PILOT STUDY WITH HUMAN G17DT IMMUNOGEN VACCINATION (2008) (0)
- Sustained response to 12-month interferon treatment in patients with chronic hepatitis C: A comparison between different IFN doses (2000) (0)
- OC.07.3 CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA PATIENTS WITH LONG-TERM SURVIVAL: AN ITA.LI.CA REPORT (2019) (0)
- OC.04.10 PROGNOSTIC ROLE OF PLATELETS-TO-LYMPHOCYTES RATIO (PLR) AND NEUTROPHILS-TO-LYMPHOCYTES RATIO (NLR) IN HEPATOCELLULAR CARCINOMA PATIENTS (2021) (0)
- 244 DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IGM IN HEPATOCELLULAR CARCINOMA (HCC) (2011) (0)
- New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC (2011) (0)
- P.01.13 ADEQUACY AND DIAGNOSTIC YIELD OF A NOVEL CORE BIOPSY NEEDLE (SHARKCORE FNB NEEDLE) IN THE DIAGNOSIS OF SUBEPITHELIAL LESIONS: OUR SERIES (2019) (0)
- P.1.274: PROTECTIVE EFFECT OF COFFEE ON OXIDATIVE DNA DAMAGE, TELOMERE LENGTH AND APOPTOSIS IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS (2011) (0)
- MALT-lymphoma (MALT-L) and lymphoepitelial gastric lesions (LEI): Associated gastritis and cytokine polymorphisms (2006) (0)
- 785 OXIDATIVE DNA DAMAGE IN PATIENTS WITH CHRONIC HCV-RELATED LIVER DISEASES: PROTECTIVE EFFECT OF COFFEE CONSUMPTION (2011) (0)
- 1039 ALPHAFETOPROTEIN AND TRANSPLANT SURVIVAL BENEFIT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTRE COHORT STUDY (2012) (0)
- P.03.7 ADHERENCE TO GUIDELINES IN THE MANAGEMENT OF ACUTE PANCREATITIS: A CLINICAL SINGLE CENTRE EXPERIENCE (2019) (0)
- 960 HEPATOCELLULAR CARCINOMA (HCC) IN HCV-RELATED CIRRHOSIS: A 20-YEARS SURVEY BY ITA.LI.CA (2011) (0)
- 671 CLINICAL FEATURES OF NON ALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC) IN ITALY: A MULTICENTER PROSPECTIVE SURVEY (2013) (0)
- Autophagy evaluation in chronic liver diseases progression (2014) (0)
- P.02.35 INTESTINAL INVOLVEMENT IN WEGENER'S GRANULOMATOSIS MIMICKING AN INFLAMMATORY BOWEL DISEASE: A CASE REPORT (2019) (0)
- SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA MEETING THE MILAN CRITERIA AWAITING LIVER TRANSPLANTATION: A COST-UTILITY ANALYSIS (2009) (0)
- Stathmin and apoptotic mediators in chronic HCV-related liver disease (2009) (0)
- INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE? (2009) (0)
- Epidemiological trends of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease in Italy. On behalf of the ITA. LI.CA study group (2020) (0)
- THU-078 - Metabolic Disorders across Hepatocellular Carcinoma in Italy (2016) (0)
- Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes (2022) (0)
- P.01.20 FREE RADICALS AND OXIDATIVE STRESS-RELATED GENOMIC DAMAGE:WHICH ROLE IN AUTOIMMUNE GASTRITIS? (2018) (0)
- Letter: is female sex really associated with better prognosis in hepatocellular carcinoma? (2021) (0)
- The outcome of low and high grade of chronic atrofic gastritis (CAG) after Helicobacter pylori infection eradication: a 3 years follow-up (2000) (0)
- Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: a multicentre cohort study (2015) (0)
- T.11.1 ASSESSMENT OF PHYSICAL FRAILTY IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: PRELIMINARY RESULTS FROM AN ONGOING PROSPECTIVE STUDY (2023) (0)
- 26 Liver transplantation for hepatocellular carcinoma (HCC): Predictive factors of HCC recurrence, an interim analysis (2003) (0)
- Therapeutic Strategies in the Real Life in BCLC-C Hepatocellular Carcinoma in Italy: Assessment in the Italian Liver Cancer and Validation in the Italian Association of Hospital Gastroenterologists Database (2016) (0)
- P0030 : Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: A multicentre cohort study (2015) (0)
- OC.14.4 NEW FORMULATION OF BISMUTH QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION WITH AND WITHOUT PROBIOTICS: EFFICACY AND SAFETY IN DAILY CLINICAL PRACTICE IN ITALY (2018) (0)
- T01.01.1 ROLE OF MIRNAS IN GASTRIC ATROPHY, AUTOIMMUNITY AND DISEASE PROGRESSION (2020) (0)
- OC.08.2 EFFECTIVENESS OF EMPIRICAL FIRST-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) (2021) (0)
- Immunohistochemical expression of ectodermin (2006) (0)
- CYSTEINE AND SERINE PROTEASES IN DUODENAL ULCER (1997) (0)
- Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (2021) (0)
- P.18.12 ANGIOGENESIS FOLLOWING CONVENTIONAL AND DC BEADS-MEDIATED TRANSCATHETER ARTERIAL EMBOLIZATION: ANY DIFFERENCE? (2013) (0)
- 789 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK (2009) (0)
- OC.05.6 GENDER-RELATED DIFFERENCES IN SCCA-IGM LEVELS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION (2020) (0)
- Gastric mucosa may activate 2-amino-fluorene (2AF) and nitrosopyrrolidine (NPY) in humans. (1988) (0)
- Adherence to BCLC Treatment Algorithm and Survival Predictors in Single Node HCC in Italy (2016) (0)
- [Intragastric pH determination as a screening test in the diagnosis of chronic atrophic gastritis]. (1989) (0)
- Sa1498 IN LIVER CANCERS, AUTOPHAGY OR APOPTOSIS, THAT IS THE QUESTION (2020) (0)
- Survival and recurrences after curative treatments of HCV-related early hepatocellular carcinoma. A meta-analysis of single arm studies (2017) (0)
- “DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?” (2017) (0)
- Lymphocyte subsets in hepatocellular carcinoma (HCC) and cirrhosis (Cirr): Effects of tymopentine treatment (1994) (0)
- TGF‐β and hepatocellular carcinoma (2008) (0)
- PA.99 PROINFLAMMATORY CYTOKINES AND NF-KB MRNA EXPRESSION IN CHRONIC LIVER DISEASES (2008) (0)
- Chemotherapy v symptomatic treatment for hepatoma. (1994) (0)
- Resting energy-expenditure (REE) in cirrhotic patients: Role of plasma concentrations of leptin and tumor necrosis factor-a (TNF-a) (2000) (0)
- Fasting hyper glycemia following trans-cathether arterial chemoembolization for hepatocellular carcinoma in cirrhosis. (1997) (0)
- T-40 Alphafetoprotein and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre cohort study (2012) (0)
- PC.01.9 ESOPHAGEAL MICROBIOTA COMPOSITION ACROSS BARRETT'S ESOPHAGUS-DYSPLASIA-EAC SEQUENCE (2019) (0)
- Erratum to: Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma (2014) (0)
- P.10.10 SCCA-IGM DETERMINATION IN BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER MIGHT REGULATE ENDOSCOPIC FOLLOW-UP SCHEDULE (2012) (0)
- Laparoscopic ablation and salvage transplantation for patients with hepatocellular carcinoma (2016) (0)
- The ITA.LI.CA Criteria to Select Patients with Hepatocellular Carcinoma for Liver Transplantation: A Multicentre Cohort Study.: Abstract# 2969 (2014) (0)
- OC.06.5 ROLE OF CYTOKINE POLYMORPHISMS IN THE PATHOGENESIS OF AUTOIMMUNE GASTRITIS (2013) (0)
- MiRNA expression in HCV-related chronic liver disease correlates with disease severity. (2009) (0)
- Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (2022) (0)
- [Changes in the gastric mucosa in the treatment of ulcerative disease]. (1986) (0)
- Increased level of presepsin in patients with acutely decompensated cirrhosis predicts development of acute-on-chronic liver failure (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabio Farinati?
Fabio Farinati is affiliated with the following schools:
